[PDF][PDF] Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

…, MF de Castro, PG de la Peña, FJ López-Longo… - The American Journal of …, 2014 - cell.com
In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with
the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human …

Association between anti–cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

FJ LópezLongo, D Oliver‐Miñarro… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular
disease that may not always be related to the presence of traditional cardiovascular risk factors…

Classification of systemic lupus erythematosus: Systemic Lupus International Collaborating Clinics versus American College of Rheumatology criteria. A comparative …

…, C Silva, M Galindo, FJ LópezLongo… - Arthritis care & …, 2015 - Wiley Online Library
Objective The new Systemic Lupus International Collaborating Clinics (SLICC) 2012
classification criteria aimed to improve the performance of systemic lupus erythematosus (SLE) …

Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis

…, CM González, FJ López-Longo… - …, 2015 - academic.oup.com
Objective. To investigate the predictive value of synovitis detected by Doppler US in relation
to failed tapering of biologic therapy (BT) in RA patients in sustained clinical remission. …

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

D Khanna, CJF Lin, DE Furst, J Goldin… - The Lancet …, 2020 - thelancet.com
Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in systemic
sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial lung …

[HTML][HTML] Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus

A Julià, FJ López-Longo, JJ Pérez Venegas… - Arthritis research & …, 2018 - Springer
Background Systemic lupus erythematosus (SLE) is a common systemic autoimmune
disease with a complex genetic inheritance. Genome-wide association studies (GWAS) have …

Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review

T Cobo-Ibáñez, E Loza-Santamaría… - Seminars in arthritis and …, 2014 - Elsevier
Objective To analyse the efficacy and safety of rituximab in the treatment of non-renal systemic
lupus erythematosus (SLE). Methods We systematically searched MEDLINE, EMBASE …

[HTML][HTML] Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

…, F Furini, FJ Lopez-Longo, J Martinez-Barrio… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

[HTML][HTML] Cardiovascular events in systemic lupus erythematosus: a nationwide study in Spain from the RELESSER registry

…, FJ Lopez-Longo, M Galindo-Izquierdo, J Calvo-Alen… - Medicine, 2015 - journals.lww.com
… Rua-Figueroa I, Lopez-Longo FJ, Calvo-Alen J, et al. National registry of patients with
systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and …

[HTML][HTML] Characterization of patients with lupus nephritis included in a large cohort from the Spanish Society of Rheumatology Registry of Patients With Systemic …

…, JM Pego-Reigosa, FJ López-Longo, J Calvo-Alén… - Medicine, 2016 - journals.lww.com
J Am Soc Nephrol 1999; 10:413–424. … J Am Soc Nephrol 1994; 4:1499–1515. … Rúa-Figueroa
I, López-Longo FJ, Calvo-Alén J, et al. Grupo de trabajo en Enfermedades Autoinmunes …